208 related articles for article (PubMed ID: 12404147)
1. [Mechanisms of immunomodulation after transfusion of allogeneic and autologous red cell concentrate].
Innerhofer P; Kühbacher G
Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Nov; 37(11):681-4. PubMed ID: 12404147
[No Abstract] [Full Text] [Related]
2. [Not overshooting the goal: comment on the contribution "Fatal endotoxic shock after transfusion of autologous erythrocyte concentrate"].
Kasper SM
Chirurg; 2001 Dec; 72(12):suppl 332-3. PubMed ID: 11824046
[No Abstract] [Full Text] [Related]
3. Pneumonia as a complication of blood product transfusion in the critically ill: transfusion-related immunomodulation (TRIM).
Vamvakas EC
Crit Care Med; 2006 May; 34(5 Suppl):S151-9. PubMed ID: 16617260
[TBL] [Abstract][Full Text] [Related]
4. Effect of packed red blood cells transfusion on plasma fibronectin during liver resection.
Kostopanagiotou G; Pandazi A; Matsota P; Arkadopoulos N; Dalamanga N; Politou M; Traulou O; Smyrniotis V
Transfus Med; 2007 Apr; 17(2):115-8. PubMed ID: 17430467
[TBL] [Abstract][Full Text] [Related]
5. [Fatal endotoxic shock after administration of autologous erythrocyte concentrate].
Wüst T; Saadé C
Chirurg; 2001 Aug; 72(8):suppl 215-7. PubMed ID: 11554149
[No Abstract] [Full Text] [Related]
6. Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty.
Innerhofer P; Klingler A; Klimmer C; Fries D; Nussbaumer W
Transfusion; 2005 Jan; 45(1):103-10. PubMed ID: 15647025
[TBL] [Abstract][Full Text] [Related]
7. Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus white cell-reduced blood to patients undergoing arthroplasty. I. Proliferative T-cell responses and the balance of helper and suppressor T cells.
Innerhofer P; Luz G; Spötl L; Hobisch-Hagen P; Schobersberger W; Fischer M; Nussbaumer W; Lochs A; Irschick E
Transfusion; 1999 Oct; 39(10):1089-96. PubMed ID: 10532603
[TBL] [Abstract][Full Text] [Related]
8. Costs associated with blood transfusions in Sweden--the societal cost of autologous, allogeneic and perioperative RBC transfusion.
Glenngård AH; Persson U; Söderman C
Transfus Med; 2005 Aug; 15(4):295-306. PubMed ID: 16101807
[TBL] [Abstract][Full Text] [Related]
9. Potential problems with autotransfusion during hepatic transplantation.
Brajtbord D; Paulsen AW; Ramsay MA; Swygert TH; Valek TR; Ramon VJ; Johnson DD; Parks RI; Pyron JT; Walling PT
Transplant Proc; 1989 Feb; 21(1 Pt 2):2347-8. PubMed ID: 2652762
[No Abstract] [Full Text] [Related]
10. [Rare posttransfusion complications and their prevention].
Popov SD; Kiselev VA; Petrenko GI; Vashchenko TN
Vestn Khir Im I I Grek; 1992 Jun; 148(6):332-3. PubMed ID: 1302984
[No Abstract] [Full Text] [Related]
11. Retrograde autologous priming and allogeneic blood transfusions: a meta-analysis.
Saczkowski R; Bernier PL; Tchervenkov CI; Arellano R
Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):373-6. PubMed ID: 19074909
[TBL] [Abstract][Full Text] [Related]
12. [Clinical relevance of immunomodulation after blood transfusion in non-oncologic patients].
Hobisch-Hagen P
Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Nov; 37(11):684-6. PubMed ID: 12404148
[No Abstract] [Full Text] [Related]
13. Blood transfusion reduction in cardiac surgery: multidisciplinary approach at a community hospital.
Brevig J; McDonald J; Zelinka ES; Gallagher T; Jin R; Grunkemeier GL
Ann Thorac Surg; 2009 Feb; 87(2):532-9. PubMed ID: 19161774
[TBL] [Abstract][Full Text] [Related]
14. [Rational substitution using stored blood and blood components].
Bünte S; Ludwig WD
Dtsch Med Wochenschr; 1994 Nov; 119(45):1555-60. PubMed ID: 7956791
[No Abstract] [Full Text] [Related]
15. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study.
Lapierre V; Aupérin A; Robinet E; Ferrand C; Oubouzar N; Tramalloni D; Saas P; Debaene B; Lasser P; Tiberghien P
Transfusion; 2007 Sep; 47(9):1691-9. PubMed ID: 17725736
[TBL] [Abstract][Full Text] [Related]
16. [A blood transfusion in Sweden--the societal cost].
Glenngård AH; Persson U
Lakartidningen; 2006 Sep 20-26; 103(38):2752-6. PubMed ID: 17058770
[No Abstract] [Full Text] [Related]
17. Salvage and transfusion of autologous red blood cells from bone marrow harvest.
Janssen WE; Benson K; Lee C; Noll L; Smilee R; Fields KK; Zorsky PE; Elfenbein GJ
Prog Clin Biol Res; 1992; 377():337-44. PubMed ID: 1438429
[No Abstract] [Full Text] [Related]
18. Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage.
Arnold DM; Molinaro G; Warkentin TE; DiTomasso J; Webert KE; Davis I; Lesiuk L; Dunn G; Heddle NM; Adam A; Blajchman MA
Transfusion; 2004 Sep; 44(9):1361-6. PubMed ID: 15318862
[TBL] [Abstract][Full Text] [Related]
19. Cellular immune response to autologous blood transfusion in hip arthroplasty: whole blood versus buffy coat-poor packed red cells and fresh-frozen plasma.
Frietsch T; Krombholz K; Tolksdorf B; Nebe T; Segiet W; Lorentz A
Vox Sang; 2001 Oct; 81(3):187-93. PubMed ID: 11703863
[TBL] [Abstract][Full Text] [Related]
20. Transfusion-related immunomodulation (TRIM): an update.
Vamvakas EC; Blajchman MA
Blood Rev; 2007 Nov; 21(6):327-48. PubMed ID: 17804128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
